Metffil VG1 Tablets

Metffil VG1 Tablet is a combination of Glimepiride, Metformin and Voglibose which belongs to the group of medicines called Antidiabetic Agents. Metffil VG1 Tablet is used in adults to treat type 2 diabetes mellitus when diet, exercise and single agents/ second line therapy with two drugs are insufficient to adequately control blood sugar level.

Metffil VG1 Tablet is not recommended for use in patients allergic to glimepiride, metformin, Voglibose, and/or other sulfonylureas/sulphonamides. It is also not recommended for use in patients with acute conditions (such as dehydration, severe infection), severe ketosis (severe complication of diabetes), severe trauma, lung problems (such as acute/chronic respiratory failure), heart problems (such as acute/chronic cardiac failure, recent myocardial infarction), and/or severe kidney/liver problems.

Before taking Metffil VG1 Tablet , inform your doctor if you recently had trauma, and/or have febrile infections, fever, uncontrolled diabetes, hypothyroidism (underactive thyroid), chronic intestinal disease, fever, other kidney/liver problems. This medicine is manufactured by Fourrts India Laboratories.

• Nausea
• Vomiting
• Diarrhoea
• Abdominal Pain
• Loss of Appetite
• Metallic taste

Warnings & Precautions

1. Kidney Function

• Regular monitoring of renal (kidney) function is essential, especially before starting the drug and periodically during use. Avoid in severe kidney impairment.

2. Liver Impairment

• Use with caution in people with liver problems due to the risk of lactic acidosis.

3. Gastrointestinal Disturbances

• Metformin and Voglibose can cause nausea, bloating, gas, and diarrhea, especially when starting treatment.

4. Alcohol Use

• Avoid excessive alcohol, as it increases the risk of lactic acidosis and hypoglycemia.

5. Pregnancy & Breastfeeding

• Not usually recommended unless clearly needed. Use only under medical supervision.

6. Surgery or Radiologic Procedures

• Discontinue temporarily if undergoing surgery or imaging procedures with contrast dye, to avoid kidney stress or lactic acidosis risk.

7. Children and Elderly

• Not typically recommended for children. Elderly patients need careful dose adjustment and close monitoring due to higher sensitivity.

Storage

• Store at room temperature, between 15°C to 30°C (59°F to 86°F).
• Do not store in the bathroom or near the kitchen sink.
• Keep the tablets in their original packaging or a light-resistant container.
• Store in a high, locked cabinet if needed.
• Check the expiration date before use.
• Freezing can damage the tablet’s effectiveness and coating.

Frequently Asked Questions

1. Is it okay to stop taking Metffil VG1 suddenly?

No. Stopping the medication suddenly can lead to uncontrolled blood sugar levels. Consult your doctor before making any changes.

2. Can I drink alcohol while taking this medication?

Avoid alcohol, as it increases the risk of lactic acidosis (a serious side effect of Metformin) and low blood sugar (due to Glimepiride).

3. What should I do if I miss a dose?

Take the missed dose as soon as you remember. If it’s almost time for your next dose, skip the missed one—don’t double up to make up for it.

4. How to take Metffil VG1 Tablets?

Take Metffil VG1 Tablets as advised by your physician. Swallow the medicine with a glass of water. Do not crush or chew the medicine. Your doctor will decide the correct dose and duration for you depending upon your age, body weight and disease condition.